NSE: BALAMINES | BSE: 530999 | ASM

Mid-range Performer

Download real time

1902.20 -13.40 (-0.70%)

25.40% Fall from 52W High

118.4K NSE+BSE Volume

NSE 08 Jul, 2025 3:31 PM (IST)

6,163.3

Market Cap

High in industry

1.3

Beta 1Year

Very High Volatility

Balaji Amines Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BALAMINES, BSE:530999 Balaji Amines Ltd.

Balaji Amines Ltd.

31 Aug 2018

1902.20

-0.70%

Balaji Amines Ltd | Q1FY19 Result Update

Buy: Balaji Amines Ltd.

Target

Edelweiss

Balaji Amines (BAL) delivered 30% topline growth led by a 19% volume and 9% pricing growth.

Balaji Amines Ltd. has an average target of 1640.00 from 1 broker.

Balaji Amines Ltd.

23 Jul 2018

1902.20

-0.70%

Balaji Amines (1QFY19): Growth levers intact! Maintain BUY

Buy: Balaji Amines Ltd.

Target

HDFC Securities

We maintain our Buy rating on Balaji Amines and value BLA at 17.0xJune'21 EPS with a revised target price of Rs 748/share. Balaji Amines (BLA IN) has been able to sustain its earnings momentum after a stellar FY18 performance. Sales/EBITDA/PAT grew by 30.0/44.6/48.6% YoY to Rs 2.6bn/Rs 587mn/Rs 338mn respectively. BLA has relentlessly worked upon growing its volumes on the back of de-bottlenecking exercises, import substitution opportunities and anti-dumping duties in place.

Number of FII/FPI investors decreased from 132 to 112 in Mar 2025 qtr

Balaji Amines Ltd.

16 May 2018

1902.20

-0.70%

Balaji Amines (4QFY18): Strong quarter and an even stronger FY19E! Maintain BUY

Buy: Balaji Amines Ltd.

HDFC Securities

We maintain Buy on Balaji Amines and value BLA at 17.0x FY20E EPS with a target price of Rs 725/share. Balaji Amines (BLA) reported a strong 4QFY18 with Sales/EBITDA/PAT growing by 33.0%/23.3%/93.4% YoY to Rs 2.56 bn/ Rs 469 mn/ Rs 332 mn respectively. Sales growth of 33.0%, was driven by 10.0% volume growth

Number of MF schemes decreased from 26 to 11 in Mar 2025 qtr

Balaji Amines Ltd.

20 Feb 2018

1902.20

-0.70%

Balaji Amines Ltd. - Result Update Q3FY18

Buy: Balaji Amines Ltd.

Target

Edelweiss

BAL has steadily built up capacity in methylamines and other specialty chemicals between FY10-FY14 riding on the strong demand potential from its key end-user industries - pharmaceuticals...

Balaji Amines Ltd. has gained 62.83% in the last 3 Months

Balaji Amines Ltd.

09 Nov 2017

1902.20

-0.70%

Balaji Amines Ltd. - High growth rider in the oligopolistic aliphatic amines industry

Buy: Balaji Amines Ltd.

Edelweiss

Balaji Amines (BAL) has steadily built up capacity in methylamines and other specialty chemicals between FY10-FY14 riding on the strong demand potential from its key end-user...

Number of MF schemes decreased from 26 to 11 in Mar 2025 qtr

Is Balaji Amines Ltd. worth buying?

383 Votes:

Buy 83.81%

Sell 9.4%

Hold 6.79%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf